Application YC di 10x Science

Winter 2026Active

10x Science ha partecipato a Y Combinator nel batch Winter 2026 come azienda B2B. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2026
Settore: B2B
Dimensione team: 3
Stato: Active
Lanciata: 2026

Founder

David RobertsFounder and CEO
Andrew ReiterFounder and COO
Vishnu TejusFounder and CTO

Cosa fa 10x Science

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development. AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with discovery. Our AI-native platform automates it, giving drug developers the confidence to advance the right candidates and stop the wrong ones early. We have strong commercial traction with enterprise pharma customers. Our founding team built the field of next-generation protein characterization out of Carolyn Bertozzi's Nobel laureate lab at Stanford. Collectively, we have 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next generation of modern AI development in the life sciences.

Application YC di 10x Science, ricostruita

Domanda per Y Combinator

10x Science, batch Winter 2026. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

10x Science

Describe what your company does in 50 characters or less.

AI-native platform for protein characterization

What is your company going to make? Please describe your product and what it does or will do.

We build an AI-native platform that automates protein characterization for drug developers. Our models have deep memory to help scientists rapidly analyze complex protein therapeutics, a process that currently takes months of manual work. This lets customers quickly decide which candidates to advance or drop.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC.

Explain your decision regarding location.

San Francisco is a biotech and AI hub where we have strong ties to pharma customers and access to top talent. Staying here keeps us close to our network and early users.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di 10x Science?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di 10x Science (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come 10x Science si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva 10x Science?

10x Science apparteneva al batch Winter 2026 di Y Combinator.

Chi ha fondato 10x Science?

10x Science è stato fondato da David Roberts, Andrew Reiter, Vishnu Tejus.

Cosa fa 10x Science?

The AI-native platform for next-generation protein characterization.

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di 10x Science, e di ogni altro batch YC, è in YC Insights.